<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The degree of effectiveness of preventive therapy with <z:chebi fb="2" ids="50249">anticoagulants</z:chebi>, following <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarctions</z:e> and in the stage of transient disorderd brain ciruclation, was studied in comparison with the frequency of repeated ischemic disorders in 166 patients, and in a control group of 138 <z:mpath ids='MPATH_458'>normals</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>During permanent administration of <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> repeated ischemic episodes appeared less frequently than with other forms of medication </plain></SENT>
<SENT sid="2" pm="."><plain>However, there was an increased amount of ischemic disorders after a discontinuation of the preparations </plain></SENT>
<SENT sid="3" pm="."><plain>The most expressed signs of such conditions were in patients with repeated <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarctions</z:e> in a low arterial pressure and especially in the stage of transient <z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">disorders of brain</z:e> circulation </plain></SENT>
<SENT sid="4" pm="."><plain>In such cases the indications for the use of <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> should be very limited </plain></SENT>
</text></document>